Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
618.20
5.95 (0.97%)
BSENSE

Aug 25, 03:30 PM

BSE+NSE Vol: 46.58 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
177.28
187.28
166.32
163.36
154.07
168.18
146.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
177.28
187.28
166.32
163.36
154.07
168.18
146.55
Raw Material Cost
58.58
73.73
47.68
57.20
60.97
53.93
50.16
Purchase of Finished goods
20.93
16.45
25.03
21.72
15.83
14.75
18.61
(Increase) / Decrease In Stocks
5.63
-1.10
3.25
-2.18
-7.42
11.48
-0.13
Employee Cost
33.31
32.46
30.62
30.36
31.76
27.62
27.98
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.01
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
31.40
40.90
36.15
30.82
29.12
33.69
26.27
Total Expenditure (Excl Depreciation)
149.85
162.43
142.73
137.93
130.26
141.46
122.89
Operating Profit (PBDIT) excl Other Income
27.43
24.85
23.59
25.43
23.81
26.72
23.66
Other Income
24.26
-4.20
15.15
7.23
15.27
-6.88
8.97
Operating Profit (PBDIT)
51.69
20.65
38.74
32.66
39.08
19.84
32.63
Interest
0.26
0.27
0.30
0.23
0.21
0.37
0.73
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
51.43
20.38
38.44
32.43
38.87
19.47
31.90
Depreciation
3.88
3.68
3.72
3.62
3.48
3.23
3.22
Profit Before Tax
47.55
16.70
34.72
28.81
35.39
16.25
28.68
Tax
11.32
5.07
6.12
8.83
7.71
4.67
7.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.23
11.63
28.60
19.98
27.68
11.58
20.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.23
11.63
28.60
19.98
27.68
11.58
20.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.23
11.63
28.60
19.98
27.68
11.58
20.77
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.03
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
18.09
5.81
14.28
9.98
13.82
5.78
10.37
Diluted Earnings per share
18.09
5.81
14.28
9.98
13.82
5.78
10.37
Operating Profit Margin (Excl OI)
15.47%
13.27%
14.18%
15.57%
15.45%
15.89%
16.14%
Gross Profit Margin
29.01%
10.88%
23.11%
19.85%
25.23%
11.58%
21.77%
PAT Margin
20.44%
6.21%
17.2%
12.23%
17.97%
6.89%
14.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 15.06% vs 4.61% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 30.89% vs 16.94% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 15.20% vs 4.75% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 23.81% vs -52.27% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Lincoln Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
177.28
121.82
55.46
45.53%
Other Operating Income
0.00
0.00
0.00
Total Operating income
177.28
121.82
55.46
45.53%
Raw Material Cost
58.58
38.75
19.83
51.17%
Purchase of Finished goods
20.93
9.78
11.15
114.01%
(Increase) / Decrease In Stocks
5.63
-6.47
12.10
187.02%
Employee Cost
33.31
23.01
10.30
44.76%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
31.40
38.69
-7.29
-18.84%
Total Expenditure (Excl Depreciation)
149.85
103.76
46.09
44.42%
Operating Profit (PBDIT) excl Other Income
27.43
18.06
9.37
51.88%
Other Income
24.26
4.37
19.89
455.15%
Operating Profit (PBDIT)
51.69
22.43
29.26
130.45%
Interest
0.26
2.54
-2.28
-89.76%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
51.43
19.89
31.54
158.57%
Depreciation
3.88
5.20
-1.32
-25.38%
Profit Before Tax
47.55
14.69
32.86
223.69%
Tax
11.32
5.16
6.16
119.38%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.23
9.53
26.70
280.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
36.23
9.53
26.70
280.17%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.21
0.21
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.23
9.74
26.49
271.97%
Equity Capital
20.03
14.34
5.69
39.68%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
18.09
3.40
14.69
432.06%
Diluted Earnings per share
18.09
3.34
14.75
441.62%
Operating Profit Margin (Excl OI)
15.47%
14.83%
0.00
0.64%
Gross Profit Margin
29.01%
16.33%
0.00
12.68%
PAT Margin
20.44%
7.82%
0.00
12.62%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 177.28 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -5.34% vs 12.60% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.06% vs 4.61% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 36.23 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 211.52% vs -59.34% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 30.89% vs 16.94% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.43 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 10.38% vs 5.34% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.20% vs 4.75% in Jun 2025

Quarterly - Interest
Interest 0.26 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -3.70% vs -10.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 23.81% vs -52.27% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.47%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025